Take a look back at our most popular respiratory coverage for 2022.
FDA, CDC Increase Availability of RSV Monoclonal Antibody for Infants
November 23rd 2023The federal agencies said that they will continue to work closely with manufacturers to maintain the availability of the vaccines through the end of 2023 and early 2024 to meet the demand during the RSV season.